Cryoport, Inc. Files 8-K on Financials
Ticker: CYRX · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1124524
| Field | Detail |
|---|---|
| Company | Cryoport, Inc. (CYRX) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Cryoport dropped an 8-K on March 12th detailing financials. Check it out.
AI Summary
On March 12, 2024, Cryoport, Inc. filed an 8-K report detailing its financial results and exhibits. The filing provides information on the company's operations and financial condition as of the reporting date.
Why It Matters
This filing provides investors with updated financial information and operational details for Cryoport, Inc., allowing for informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Cryoport, Inc. (company) — Registrant
- March 12, 2024 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- Brentwood, TN (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details are not provided in the header.
When was this 8-K report filed?
The report was filed on March 12, 2024.
What is Cryoport, Inc.'s state of incorporation?
Cryoport, Inc. is incorporated in Nevada.
Where are Cryoport, Inc.'s principal executive offices located?
The principal executive offices are located at 112 Westwood Place, Suite 350, Brentwood, TN 37027.
What is the SIC code for Cryoport, Inc.?
The Standard Industrial Classification (SIC) code for Cryoport, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 512 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-03-12 16:30:29
Key Financial Figures
- $0.001 — e on which registered Common Stock, $0.001 par value CYRX The NASDAQ Stock Mar
Filing Documents
- tm248611d1_8k.htm (8-K) — 27KB
- tm248611d1_ex99-1.htm (EX-99.1) — 203KB
- tm248611d1_ex99-1img001.jpg (GRAPHIC) — 8KB
- 0001104659-24-033491.txt ( ) — 432KB
- cyrx-20240312.xsd (EX-101.SCH) — 3KB
- cyrx-20240312_lab.xml (EX-101.LAB) — 33KB
- cyrx-20240312_pre.xml (EX-101.PRE) — 22KB
- tm248611d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On March 12, 2024, Cryoport, Inc. (the "Company") issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2023. A copy of the press release issued by the Company is attached hereto as Exhibit 99.1. The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K: Exhibit Number 99.1 Press Release dated March 12, 2024 issued by the Company.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 12, 2024 Cryoport, Inc. /s/ Robert Stefanovich Robert Stefanovich Chief Financial Officer